Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 1063-1067

  Ito, Kensaku ^a   Yano, Tokujiro ^a   Morodomi, Yosuke ^a   Yoshida, Tsukihisa ^a   Kohno, Mikihiro ^a   Haro, Akira ^a   Shikada, Yasunori ^a   Okamoto, Tatsuro ^a   Maruyama, Riichiroh ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti oxidant capacity; BAP test; D Roms test; DNA damage; Never smokers; Oxidative stress; Primary lung cancer; Thymidine glycol

Indexed keywords

5,6 DIHYDRO 5,6 DIHYDROXYTHYMIDINE; DNA; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; DISEASE SEVERITY; DNA DAMAGE; FEMALE; HEALTH STATUS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIMARY TUMOR; PRIORITY JOURNAL; SMOKING; SMOKING HABIT;

AGED; ANTIOXIDANTS; DNA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; OXIDATIVE STRESS; SMOKING;

EID: 84858779334     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D, Flanders WD, Jee SH, Katanoda K, Kolonel LN, Lee IM, Marugame T, Palmer JR, Riboli E, Sobue T, Avila-Tang E, Wilkens LR and Samet JM: Lung cancer occurrence in never-smokers: An analysis of 13 cohorts and 22 cancer registry studies. PLOS Med 5: 1357-1371, 2008.
2. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK and West DW: Lung cancer incidence in never smokers. J Clin Oncol 25: 472-478, 2007. (Pubitemid 350002951)
3. Boffetta P, Järvholm B, Brennan P and Nyrén O: Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer 94: 591-593, 2001.
4. Yano T, Miura N, Takenaka T, Haro A, Okazaki H, Ohba T, Kouso H, Kometani T, Shoji F and Maehara Y: Never-smoking non-small cell lung cancer as a separate entity - The clinicopathologic features and survival. Cancer 113: 1012-1018, 2008.
5. Yano T, Haro A, Shikada Y, Maruyama R and Maehara Y: Non-small cell lung cancer in never smokers as a representative of 'non-smoking-associated lung cancer' -Epidemiology and clinical features-. Int J Clin Oncol 16: 287-293, 2011.
6. Valavanidis A, Vlachogianni T and Fiotakis K: Tobacco smoke: Involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 6: 445-462, 2009.
7. Church DF and Pryor WA: Free radical chemistry of cigarette smoke and its toxicological implication. Environ Health Perspect 64: 111-126, 1985. (Pubitemid 16135783)
8. Kalta J, Chaudhary AK and Prasad K: Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 72: 1-7, 1991.
9. Cadet J, Douki T and Ravanat J-L : Oxidatively generated base damage to cellular DNA. Free Radic Biol Med 49: 9-21, 2010.
10. Hair JM, Terzoudi GI, Hatzi VI, Lehockey KA, Srivastava D, Wang W, Pantelias GE and Georgakilas AG: BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions. Chem-Biol Interact 188: 350-358, 2010.
11. You M, Candrian U, Maronpot RR, Stoner GD and Anderson MW: Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86: 3070-3074, 1989. (Pubitemid 19129560)
12. Calvez FL, Mukeria A, Hunt JD, Kelm O, Hung RJ, Taniere P, Brennan P, Boffetta P, Zaridze DG and Hainaut P: TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: Distinct patterns in never, former, and current smokers. Cancer Res 65: 5076-5083, 2005. (Pubitemid 40827316)
13. Yano T, Shoji F, Baba H, Koga T, Shiraish T, Orita H and Kohno T: Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients. Lung Cancer 63: 111-114, 2009.
14. Lee YJ, Cho BC, Jee SH, Moon JW, Kim SK, Chang J, Chung KY, Park IK, Choi SH and Kim JH: Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small cell lung cancer. J Clin Oncol 28: 487-492, 2010.
15. Mok TS, Wu YL, Thongprasent S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA and Fukuoka M: Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361: 947-957, 2009.
16. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japanese Society for the Study of Obesity. New criteria for 'Obesity Disease' in Japan. Circ J 66: 987-992, 2002.
17. Mountain CF: Revisions in international staging system for lung cancer. Chest 111: 1710-1717, 1997
18. AlbertiA, Bolognini L, Macciantelli D and Carratelli M: The radical cation of N,N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem Interrmed 26: 253-267, 2000.
19. Cornelli U, Terranova R, Luca S, Cornelli M and Alberti A: Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr 131: 3208-3211, 2001. (Pubitemid 33136136)
20. Tsuchiya M, Sato E, Inoue M and Asada A: Open abdominal surgery increases intraoperative oxidative stress: Can it be prevented? Anesth Analg 107: 1946-1952, 2008.
21. Vassalle C, Boni C, Di Cecco P and Landi P: Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Int J Cardiol 110: 415-416, 2006. (Pubitemid 43831222)
22. Ridker PM, Brown NJ, Vaugham DM, Harrison DG and Mehta JL: Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109: IV 6-19, 2004.
23. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A and Tanooka H: Formation of 8-hydroxyguaine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 7: 1849-1851, 1986.